RxP Weekly Reader: Spring Forward edition #39
It was a big week for the AMSA Scorecard, which popped up in the New York Times story about Harvard Medical School’s extensive ties to industry and what some medical students and faculty are doing to bring them to light. The story topped the most-read col
Supreme Court protects consumer rights in Wyeth v. Levine
The much-anticipated decision in the case Wyeth v. Levine was announced today, in which the Court rejected, 6-3, the drug industry’s argument that FDA’s approval of a drug’s label should be a shield from liability under state tort law.
We’re as excited as
Supreme Court Protects Consumer Rights in Wyeth v. Levine
Today, the Supreme Court rejected arguments by the prescription drug industry that having their labels approved by the Food and Drug Administration should be a shield from state law tort liability. In a rousing victory for consumers of prescription drug
AAFP diagnosis needs second opinion
The president of American Academy of Family Physicians, Dr. Ted Epperly, has misdiagnosed the Physician Payments Sunshine Act, claiming it would place “onerous” and “undue burdens” on physicians.
"It gets into every little detail," Epperly tells AAFP News
Disclosure of research payments: One step forward, two steps back?
Pfizer announced today that it will begin to disclose payments made to physicians in a public online database beginning in the first half of 2010. Not only does this signal another Big (+ Wyeth = Bigger!) Pharma player hopping on the voluntary disclosure
Grassley, Kohl file NIH conflict amendment, hold the line on Sunshine
An amendment put forward today by Sens. Charles Grassley (R-IA) and Herb Kohl (D-WI) as part of the Senate’s economic recovery bill would better illuminate conflicts in federal biomedical grants by requiring the National Institutes of Health to enforce it
RxP Weekly Reader: Groundhog Day Edition #38
It's Monday, which means the Arizona Cardinals' championship dreams go back into hibernation* for at least another year, and it's six more weeks of winter for the rest of us, at least if you believe the groundhog.
In the pocket: States introduce bills to
Sen Grassley: Next FDA Commish should have no industry ties
Asked this morning about the qualities needed in the next FDA commissioner, Sen. Charles Grassley (R-IA) called for "somebody outside of FDA and with no ties to the pharmaceutical industry."
Speaking at the annual Families USA conference in Washington D.C
Wave of disclosure follows Sunshine Act introduction
A flurry of medical organizations have announced their own disclosure policies following the reintroduction of the Physician Payments Sunshine Act last week.
The Star-Tribune reports that Park Nicollet, a large Minnesota health provider network joins the